山东大学教师主页 Hui Li Site-specific nanoswitch circumventing immune resistance via activating TLR and inhibiting PD-L1/PD-1 axis Home

Site-specific nanoswitch circumventing immune resistance via activating TLR and inhibiting PD-L1/PD-1 axis

Release Time:2024-05-18 Hits:

Institution:药学院
Journal:Journal of Controlled Release
First Author:Hao, Yanyun
Document Code:1703664058821718017
Volume:361
Page Number:64-76
Number of Words:8
Translation or Not:No
Date of Publication:2023-09

Prev One:Recent advances of novel targeted drug delivery systems based on natural medicine monomers against hepatocellular carcinoma

Next One:Ferrocene-conjugated polymeric platform via amide bond formation facilitates enhanced in situ fenton reaction and robust immune responses in combination with toll-like receptor 7/8 agonist

Home

Scientific Research

Teaching Research

Awards and Honours

Enrollment Information

Student Information

My Album

Blog

Personal Information

Other Contact Information

Site-specific nanoswitch circumventing immune resistance via activating TLR and inhibiting PD-L1/PD-1 axis